Drug Type Small molecule drug |
Synonyms GSK 2245035 |
Target |
Action agonists |
Mechanism TLR7 agonists(Toll like receptor 7 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC24H38N6O6 |
InChIKeyMWVXFHFYGZBEBN-DASCVMRKSA-N |
CAS Registry1325212-97-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allergic asthma | Phase 2 | Germany | 05 Dec 2016 | |
Allergic asthma | Phase 2 | United Kingdom | 05 Dec 2016 | |
Ige Responsiveness, Atopic | Phase 2 | Canada | 01 Mar 2013 | |
Asthma | Phase 2 | Canada | 01 Apr 2012 | |
Rhinitis, Allergic, Perennial | Phase 2 | Canada | 01 Apr 2012 | |
Rhinitis, Allergic, Seasonal | Phase 1 | Netherlands | 30 May 2011 |
Phase 2 | 36 | xmgawreedk(nklmpcbcss) = zfbfvevsxy igkpvbzkck (plklwkdhvj ) | Positive | 09 Nov 2020 | |||
Placebo | xmgawreedk(nklmpcbcss) = wzfhicgvxo igkpvbzkck (plklwkdhvj ) | ||||||
Phase 2 | 36 | Placebo Nasal Spray Solution (Placebo) | cwltxyvgoc(gyamtihsjd) = tpoplwhqsq soqdzjjqcm (thrcnkrqal, 0.7195) View more | - | 15 May 2019 | ||
(GSK2245035 20 ng) | cwltxyvgoc(gyamtihsjd) = udiojecvbk soqdzjjqcm (thrcnkrqal, 0.5353) View more |